These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 187320)

  • 21. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of total hemolytic complement in sera from hamsters bearing herpes simplex type 2-induced tumors.
    Márquez ED; Backenstose JM; Chapman JL
    Cancer Res; 1980 Mar; 40(3):713-6. PubMed ID: 6258785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 25. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
    Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
    Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
    [No Abstract]   [Full Text] [Related]  

  • 27. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 29. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma.
    Christenson B
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
    Møller-Larsen A
    J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
    Aurelian L; Strnad BC
    Cancer Res; 1976 Feb; 36(2 pt 2):810-20. PubMed ID: 175945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.
    Skinner GR
    Br J Exp Pathol; 1976 Aug; 57(4):361-76. PubMed ID: 183803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme immunoassay for detection of antibodies against herpes simplex virus with the use of different viral antigens.
    Maltseva NN; Zvonarev AYu ; Matsevich GR; Ebralidze LK
    Acta Virol; 1987 May; 31(3):226-33. PubMed ID: 2888286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
    Freymuth F; Morel C; Longson A; Tanguy M
    Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic relationship between herpes simplex viruses, human cervical cancer and HSV-associated hamster tumours.
    Nahmias AJ; Del Buono I
    IARC Sci Publ (1971); 1975; (11 Pt 1):309-13. PubMed ID: 190133
    [No Abstract]   [Full Text] [Related]  

  • 40. Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva.
    Kaufman RH; Dreesman GR; Burek J; Korhonen MO; Matson DO; Melnick JL; Powell KL; Purifoy DJ; Courtney RJ; Adam E
    N Engl J Med; 1981 Aug; 305(9):483-8. PubMed ID: 6265780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.